2012
DOI: 10.2165/11632160-000000000-00000
|View full text |Cite
|
Sign up to set email alerts
|

Nutraceuticals for Blood Pressure Control in Patients with High-Normal or Grade 1 Hypertension

Abstract: Our results show that the addition of Orthosiphon stamineus to the combination of nutraceuticals confers an antihypertensive effect that allows a surprisingly effective 24-hour BP control in hypertensive patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 20 publications
0
9
0
Order By: Relevance
“…In clinical studies, it was been tested as an additional regimen for antihypertensive treatment (Trimarco et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…In clinical studies, it was been tested as an additional regimen for antihypertensive treatment (Trimarco et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the NCs, in light of their properties, are free from relevant side effects. This approach is not completely new [10][11][12], as macro-and micronutrient deficiencies are very common in the general population and may be even more common in subjects with HT and HCh due to genetic or environmental causes and prescription drug use [13].…”
Section: Introductionmentioning
confidence: 99%
“…Coenzyme Q10 has consistent and significant antihypertensive effects in patients with essential hypertension [1,[308][309][310][311][312][313][314][315][316][317] . The literature is summarized below: (1) Compared to normotensive patients, essential hypertensive patients have a higher incidence (6 fold) of coenzyme Q10 deficiency documented by serum levels [1] ; (2) Doses of 120 to 225 mg/d of coenzyme Q10, depending on the delivery method or the concomitant ingestion with a fatty meal, are necessary to achieve a therapeutic level of 3 ug/mL [1,313,314] .…”
Section: Coenzyme Q10 (Ubiquinone)mentioning
confidence: 99%